fbpx

ABD

About This Project

Biofilms are a mounting problem in modern medicine. A leading source of fouling on equipment, patient reinfections, and drug-resistant bacteria, healthcare systems are faced with limited responses. Aequor has developed the Aequor Biofilm Dispersant to address this matter, breeding a DNA sequence from marine microbes into an E. coli-based delivery system to break down these organic barriers and allow other antimicrobials to do their work. ABD is 99% effective against biofilms formed by Gram-negative and Gram-positive bacteria and fungi, is non-destructive, and provokes no bacterial resistance response at effective concentrations, making it sustainably effective. In some cases, there has not been a new antibiotic solution in over 40 years. The feasibility study will examine the viability of the ABD as an antibiotic and drug-additive to improve clinical outcomes and make EU healthcare more sustainable.

Topic
BioHealth
Cutoff

September

Year

2016

Beneficiaries

Coordinator

AEQUOR LTD

Country

United Kingdom

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.


Warning: mysqli_num_fields() expects parameter 1 to be mysqli_result, bool given in /home/alientt8/public_html/wp-includes/wp-db.php on line 3351